LabCorp
LH
#1078
Rank
NZ$39.46 B
Marketcap
NZ$481.23
Share price
1.93%
Change (1 day)
12.17%
Change (1 year)
Laboratory Corporation of America Holdings or LabCorp is a US company that offers clinical laboratory services. The company supplies laboratory results for the diagnosis of diseases and the development of new drugs.

EPS for LabCorp (LH)

EPS in 2026 (TTM): NZ$19.40

According to LabCorp's latest financial reports the company's current EPS (TTM) is NZ$20.14. In 2025 the company made an earnings per share (EPS) of NZ$18.67 an increase over its 2024 EPS that were of NZ$15.76.

EPS history for LabCorp from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$19.403.95%
2025NZ$18.6718.45%
2024NZ$15.7689.15%
2023NZ$8.33-66.26%
2022NZ$24.69-43.33%
2021NZ$43.5754.11%
2020NZ$28.2789.43%
2019NZ$14.93-3.33%
2018NZ$15.44-29.7%
2017NZ$21.9675.74%
2016NZ$12.5063.19%
2015NZ$7.66-28.4%
2014NZ$10.70-6.13%
2013NZ$11.395.2%
2012NZ$10.83

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
IDEXX Laboratories
IDXX
NZ$24.29 20.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$16.26-19.28%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
NZ-$1.49-107.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
NZ$3.65-81.87%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
NZ-$0.37-101.85%๐Ÿ‡บ๐Ÿ‡ธ USA